Pinnacle Financial Partners (Tennessee)’s Charles River Laboratories CRL Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-130	Closed	-$35.2K	–	525
2024 Q2	$35.2K	Hold	130	–	–	﹤0.01%	493
2024 Q1	$35.2K	Hold	130	–	–	﹤0.01%	488
2023 Q4	$30.7K	Hold	130	–	–	﹤0.01%	474
2023 Q3	$25.5K	Hold	130	–	–	﹤0.01%	459
2023 Q2	$27.3K	Hold	130	–	–	﹤0.01%	465
2023 Q1	$26.2K	Hold	130	–	–	﹤0.01%	460
2022 Q4	$28.3K	Hold	130	–	–	﹤0.01%	446
2022 Q3	$26K	Buy	+130	New	+$28.1K	﹤0.01%	441
2022 Q2	–	Sell	-134	Closed	-$38K	–	435
2022 Q1	$38K	Hold	134	–	–	﹤0.01%	397
2021 Q4	$50K	Hold	134	–	–	﹤0.01%	417
2021 Q3	$55K	Hold	134	–	–	﹤0.01%	399
2021 Q2	$50K	Buy	+134	New	+$44.7K	﹤0.01%	393

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s CRL Position: Q3 2024 in Review

Pinnacle Financial Partners (Tennessee) sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 130 shares — an estimated $35.2K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in CRL in Q2 2021 and held it in 12 quarters. The position peaked at $55K in Q3 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

Pinnacle Financial Partners (Tennessee) reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
Pinnacle Financial Partners (Tennessee) sold 130 Charles River Laboratories shares in Q3 2024, an estimated $35.2K.
Pinnacle Financial Partners (Tennessee) first reported a position in Charles River Laboratories in Q2 2021 and held it in 12 quarters.
Pinnacle Financial Partners (Tennessee)'s Charles River Laboratories position peaked at $55K in Q3 2021.
628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2024, filed 5 Nov 2024.